01 · Tasly Media
Medicinally Active Cells
Culture systems engineered to preserve identity, purity, potency and aging resistance.
- Tissue-origin identity
- Freedom from heterogeneity
- High personalized potency
- Aging resistance
Tianjin · China · Est. Tasly Group
Pioneering cell-based
rejuvenation for
personalized healthcare.
Tasly Institute of Life Rejuvenation develops AI-aided, cell-based organ rejuvenation strategies — moving healthcare from disease-based medication toward personalized, precision intervention.
150+
Case reports
36
Young scientists
6
Disease areas
REJUVO
Life Rejuvenation Core
Mesenchymal Stromal Cells◆AI-Aided Omics◆DEVELOR Strategy◆CELLOIMX Detection◆Microcirculation Repair◆Personalized Rejuvenation◆
Mesenchymal Stromal Cells◆AI-Aided Omics◆DEVELOR Strategy◆CELLOIMX Detection◆Microcirculation Repair◆Personalized Rejuvenation◆
Mesenchymal Stromal Cells◆AI-Aided Omics◆DEVELOR Strategy◆CELLOIMX Detection◆Microcirculation Repair◆Personalized Rejuvenation◆
Mission
From disease-based medication to personalized healthcare.
Transform disease-based medication into personalized healthcare through AI-aided integration of cell-based organ rejuvenation.
01
Transformative Vision
Revolutionize healthcare through personalized cell therapies and organismal rejuvenation strategies.
02
Innovative Science
Novel strategies with Mesenchymal Stromal Cells (MSCs) as powerful biological modulators.
03
Core Mission
Bridge cutting-edge science with real-world regenerative healthcare solutions.
The Science
Mesenchymal Stromal Cells.
Not conventional stem cells — MSCs are medicinally active stromal cells that regulate the tissue microenvironment, vascular stability, immune activity and endogenous repair.
◆
Multipotent Potential
Self-renewal and differentiation into multiple cell types under specific conditions.
◆
Immunomodulation
Regulate immune responses, reduce inflammation and promote healing via cytokines and signaling factors.
◆
Clinical Recognition
Milestone regulatory progress in steroid-refractory graft-versus-host disease supports MSCs' therapeutic relevance.
Foundation
Structural & functional integrity of the vascular system.
Strategy — DEVELOR
Destination-engaged & vascular evolving-linked organismal rejuvenation.
A therapeutic framework in which medicinally active cells help remodel the tissue microenvironment, promote angiogenesis, revive injury signals and guide organ system rejuvenation.
01
Medicinally Active Cells
Remodel the tissue microenvironment through calibrated MSC preparation.
02
Pro-Angiogenesis
Restore microcirculation and enable effective cell homing to injured tissues.
03
Revive Injury Signals
Reactivate endogenous adult stem cells within the correct time window.
04
Functional Repair
Guide organ system rejuvenation and durable functional recovery.
Solutions & Platforms
Four pillars of cell-based rejuvenation.
From preparation to quality, timing and delivery — each platform is engineered around a single, coherent scientific model.
02 · 3P Quality
Property · Purity · Potency
AI-aided single-cell omics defines signatures and releases only high-potency, homogeneous products.
- Single-cell transcriptomics
- Designated culture conditions
- AI release criteria
03 · Homeostatic Profile
Intervention Timing
Organs-on-a-chip + proteomics build a personalized profile defining the correct intervention window.
- Personalized proteomics
- Organs-on-a-chip
- AI window prediction
04 · Pro-Angiogenesis
Effective Cell Homing
Tissue-specific pro-angiogenesis restores microcirculation so exogenous MSCs reach targets.
- Microcirculation repair
- Tissue-specific targeting
- IP-protected approach
Platform Spotlight
CELLOIMX Cell Detection
A label-free cell detection chip integrated with big-data-model-driven algorithmic screening. Counts, sizes, analyzes and predicts risk for every cell product.
Label-free cytometry
GMP / GCP compliance
AI-integrated CQA report
Instant readout
Applications
Where rejuvenation meets the human body.
Cell-based rejuvenation is being explored across cardiovascular, autoimmune, metabolic, neurological and homeostatic contexts.
Cardiovascular
Heart tissue repair, microcirculation recovery, post-injury functional support and vascular remodeling.
Research focus
Autoimmune
Immune regulation and modulation of chronic inflammatory microenvironments with personalized profiling.
Research focus
Pediatric GvHD
MSC-based therapy for steroid-refractory graft-versus-host disease contexts.
Research focus
Neurological
Investigating Parkinson's, stroke recovery and cognitive rejuvenation pathways.
Research focus
Metabolic
Hypertension, diabetes and pulmonary arterial hypertension case-report focus.
Research focus
Sleep & Homeostasis
Insomnia and personalized homeostatic profile interventions.
Research focus
Case Reports
150+ patient-reported outcomes across six disease areas.
Selected patient-reported outcomes shared for reference. Content is illustrative of case-report material and does not constitute medical claims.
10+
Heart Failure
35+
Hypertension
15+
Pulmonary AH
25+
Diabetes
35+
Stroke
45+
Insomnia
HypertensionJun 10, 2025
"I feel so good to inhale the fresh air again — what a relief!"
Heart failure · HypothyroidismFeb 21, 2025
"I can walk without getting worn out — it's lovely to be out and about again."
Coronary · DiabetesSep 13, 2024
"Tucking into hot pot again, all by myself — brilliant!"
InsomniaApr 9, 2024
"Finally, I am having sound sleep again."
Parkinson's DiseaseOct 26, 2023
"I'm back to having a kickabout with my grandson — a nice feeling!"
Patient-reported outcomes are anecdotal case-report material shared by the institute. They are not statements of clinical efficacy and should not be interpreted as medical claims.
Insight Platform
Real-time scientific updates.
The Insight platform bypasses traditional publication delays to share standards, technologies and collaborative opportunities globally.
Jun 3, 2025Review
Thirty Years of Cognitive Evolution in MSC Therapy
From 'mesenchymal stem cells' to mesenchymal stromal cells — a mechanism-driven repositioning.
Read insight
May 8, 2025Insight
Stem Cells 'Cure All Diseases' — Not a Myth
Why MSCs are more accurately stromal cells that regulate vessels, signals and endogenous repair.
Read insight
Apr 14, 2025Guidance
Three Questions Before Undergoing 'Stem Cell' Therapy
Cell identity, mechanism of action and validated quality standards.
Read insight
Recent News
2024 — 2025
- Nov 5, 2025TILRTasly Group becomes official collaborator of STEMCELL-2026.
- Apr 10, 2025U.S. FDAFDA announces plan to phase out animal testing requirement for monoclonal antibodies.
- Mar 20, 2025JSRMJSRM publishes recommendations for safe implementation of intravenous administration.
- Dec 18, 2024U.S. FDAFirst MSC therapy approved for steroid-refractory acute GvHD.
Team
36 young genius minds.
A team of scientists under 40 pushing the boundaries of cellular rejuvenation, MSC biology, AI-driven analysis and regenerative medicine.
36
Scientists <40
Patents
Filed IP
Papers
Peer-reviewed
Awards
International
J
Dr. Xin Jin
Chief Cellular Biologist
MSC differentiation pathways · Harvard Medical School · pioneering work in exosome therapeutics.
L
Dr. Jin Lai
Head of AI & Bioinformatics
MIT PhD · predictive models for cell therapy outcomes with advanced machine learning.
Z
Dr. Yaya Zhang
Lead Geneticist
Princeton · CRISPR applications in MSC engineering · 12 patents in cell modification.
Collaborations
Global scientific partnerships.
Academic medical centers, clinical trial consortiums across Asia, Europe and North America, and fellowship programs shaping the next generation of cell therapy specialists.
Partnership formats
Technology licensingJoint research programsClinical trial partnershipsTranslational researchAI & omics collaborationsCell therapy QCPersonalized rejuvenation
Contact
Speak with our scientific team.
Tell us about your application, partnership interest or research collaboration and our team will respond with the most relevant technical information.
Email
partnerships@taslyinstitute.cn
Phone
+86 22 8319 XXXX
Address
Tasly Life Science Innovation Park, Xiqing District, Tianjin 300380, China
Compliance
Content shared on this website is intended for scientific and business inquiries. It is not medical advice. Clinical and regulatory statements should be verified with primary sources.